Video
Expert discusses limitations of the vitamin D blood test
Author(s):
“The idea of generally screening everyone right now is not only costly, but it's not recognizing the fact that this comes with a lot of limitations,” says Mark A. Moyad, MD, MPH.
Video Player is loading.
In this video, Mark A. Moyad, MD, MPH, discusses the limitations of vitamin D blood tests, focusing on the possibility for low or high levels of vitamin D to be misinterpreted. Moyad is the Jenkins/Pomkempner Director of Complementary Alternative Medicine in the Department of Urology at the University of Michigan Medical Center in Ann Arbor, Michigan.
Related Videos
Case 1: A 79-Year-Old Man With Non–Muscle-Invasive Bladder Cancer
Case 2: A 63-Year-Old Man With Recurrent HSPC
Comorbidities and Adherence: Tailoring mHSPC Treatment
Clinical Outcomes of Ultra-Low PSA Responses in Patients With mHSPC Receiving Darolutamide Plus ADT
Treatment or Lack of Treatment of Small Renal Masses
The current treatment landscape of mHSPC
Strengths and Weaknesses of Imaging Modalities in ccRCC
BPH: Strategies for Guiding Patients From Medication to Intervention
Representation of Black men with mHSPC in clinical trials
Post Hoc Analysis of ARANOTE; Ultra-Low PSA Responses
Related Content
